Back

Early clinical and hemodynamic comparison of the latest-generation Evolut FX and SAPIEN 3 Ultra RESILIA Valves in transcatheter aortic valve implantation

1 September 2025 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Interventional treatment of aortic stenosis: procedure and outcome Intervention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Norihito Takahashi

Juntendo University Graduate School of Medicine, Tokyo (Japan)

3 More presentations in this session

Presentation thumbnail
Periprocedural and postprocedural outcomes of patients with tricuspid aortic valve undergoing transcatheter aortic valve implantation with the myval valve
Doctor N. Ktenopoulos (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Single-center prospective study of accurate neo 2 in valve-in-valve TAVI: procedural and mid-to-long term outcomes
Doctor G. Papadopoulos (Thessaloniki, GR)
Abstract Slides Video
Presentation thumbnail
Accurate Neo prosthetic valve for percutaneous treatment of pure aortic regurgitation
Mr L. Dominguez Rodriguez (Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Interventional treatment of aortic stenosis: procedure and outcome

The Event

Event poster

ESC Congress 2025

1 September 2025 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Comparison of the prevalence of hemolysis between the latest balloon-expandable and self-expandable valves
thumbnail
Congress Presentation
The comparison of echocardiographic and serum parameters between Sapien 3 Ultra Resilia and Sapien 3 at one month
thumbnail
Congress Presentation
Impact of SAPIEN3 Ultra RESILIA on improvement of valve performance: Insights from the multicenter registry: a propensity-score matched analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources